Filing Details
Pyxis Oncology, Inc. (NASDAQ:PYXS) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:PYXS
Pyxis Oncology, Inc. (PYXS) Reports Material Event to SEC
Filing Details Pyxis Oncology, Inc. (NASDAQ:PYXS) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context Pyxis…
Market Context
Pyxis Oncology, Inc.'s stock currently trades at $2.63 with a market capitalization of $274.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Pyxis Oncology, Inc.'s stock.
All SEC filings for Pyxis Oncology, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PYXS Stock Page
Frequently Asked Questions
Where can I read PYXS's SEC filings?
Browse all filings on our PYXS SEC filings page.
What types of SEC filings does Pyxis Oncology, Inc. file?
Public companies like Pyxis Oncology, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.